Atypical Chronic Myeloid Leukemia

Oncology·MeSH: Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Prevalence

12.0 / 100K

Incidence

1.9 / 100K/yr

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Atypical Chronic Myeloid Leukemia?

There are 1 clinical trial targeting Atypical Chronic Myeloid Leukemia tracked by BioSniper.

What is the prevalence of Atypical Chronic Myeloid Leukemia?

The estimated prevalence of Atypical Chronic Myeloid Leukemia is approximately 12.0 per 100,000 population.

Deep-dive into Atypical Chronic Myeloid Leukemia

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Atypical Chronic Myeloid Leukemia — Drugs in Development & Clinical Trials | BioSniper